{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T20:21:46Z","timestamp":1787516506203,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001475","name":"Nanyang Technological University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001475","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cgh.2026.07.002","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:28:08Z","timestamp":1783726088000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Timing of Antiplatelet and Anticoagulant Therapy Resumption Following Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8122-832X","authenticated-orcid":false,"given":"Yihang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangzheng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson Wen Bin","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin K.F.","family":"Tsoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3125-5199","authenticated-orcid":false,"given":"Joseph J.Y.","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2026.07.002_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cgh.2019.05.017","article-title":"Risk of gastrointestinal bleeding increases with combinations of antithrombotic agents and patient age","volume":"18","author":"Abraham","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.07.002_bib2","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/eurheartj\/ehw454","article-title":"Management of antithrombotic therapy after bleeding in patients with coronary artery disease and\/or atrial fibrillation: expert consensus paper of the European Society of cardiology working group on thrombosis","volume":"38","author":"Halvorsen","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cgh.2026.07.002_bib3","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Dav\u00ec","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2026.07.002_bib4","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/j.jacc.2010.09.017","article-title":"Novel anticoagulants for stroke prevention in atrial fibrillation","volume":"56","author":"Schirmer","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cgh.2026.07.002_bib5","article-title":"Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study","volume":"351","author":"Staerk","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2026.07.002_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1272971","article-title":"Novel strategies in antithrombotic therapy: targeting thrombosis while preserving hemostasis","volume":"10","author":"Sim","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cgh.2026.07.002_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/postgradmedj-2017-135276","article-title":"Stopping antithrombotic therapy after acute upper gastrointestinal bleeding is associated with reduced survival","volume":"94","author":"Siau","year":"2018","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.cgh.2026.07.002_bib8","first-page":"322","article-title":"Management dilemmas in restarting anticoagulation after gastrointestinal bleeding","volume":"35","author":"Jain","year":"2022","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.cgh.2026.07.002_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-152-1-201001050-00179","article-title":"Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial","volume":"152","author":"Sung","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2026.07.002_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/gutjnl-2017-315131","article-title":"Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines","volume":"67","author":"Chan","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2026.07.002_bib11","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/gutjnl-2020-323846","article-title":"Towards personalised management for non-variceal upper gastrointestinal bleeding","volume":"70","author":"Sung","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2026.07.002_bib12","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/archinternmed.2012.4261","article-title":"Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding","volume":"172","author":"Witt","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2026.07.002_bib13","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.amjcard.2013.10.044","article-title":"Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation","volume":"113","author":"Qureshi","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cgh.2026.07.002_bib14","doi-asserted-by":"crossref","first-page":"S331","DOI":"10.14309\/01.ajg.0000591844.43161.84","article-title":"Resuming anticoagulation following hospitalization for gastrointestinal bleeding is associated with reduced thromboembolic events and improved mortality: results from a systematic review and meta-analysis","volume":"114","author":"Tapaskar","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.07.002_bib15","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/biomedicines11020554","article-title":"No Association between gastrointestinal rebleeding and DOAC therapy resumption: a systematic review and meta-analysis","volume":"11","author":"P\u00e1link\u00e1s","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.cgh.2026.07.002_bib16","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00228-022-03300-7","article-title":"Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with prior gastrointestinal bleeding: a network meta-analysis of real-world data","volume":"78","author":"Hu","year":"2022","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.cgh.2026.07.002_bib17","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2026.07.002_bib18","series-title":"Practical Statistics for Medical Research","author":"Altman","year":"1990"},{"key":"10.1016\/j.cgh.2026.07.002_bib19","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/biom.13197","article-title":"Optimal approximate conversions of odds ratios and hazard ratios to risk ratios","volume":"76","author":"VanderWeele","year":"2020","journal-title":"Biometrics"},{"key":"10.1016\/j.cgh.2026.07.002_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039471","article-title":"Evolution of Heterogeneity (I2) estimates and their 95% confidence intervals in large meta-analyses","volume":"7","author":"Thorlund","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2026.07.002_bib21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jclinepi.2019.10.015","article-title":"GRADE guidelines 27: how to calculate absolute effects for time-to-event outcomes in summary of findings tables and Evidence Profiles","volume":"118","author":"Skoetz","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cgh.2026.07.002_bib22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1742-1241.2011.02827.x","article-title":"Risks related with withholding and resuming anticoagulation in patients with non-variceal upper gastrointestinal bleeding while on warfarin therapy","volume":"66","author":"Lee","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.cgh.2026.07.002_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cgh.2012.08.034","article-title":"Discontinuation of low-dose aspirin therapy after peptic ulcer bleeding increases risk of death and acute cardiovascular events","volume":"11","author":"Derogar","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.07.002_bib24","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3109\/0886022X.2013.819766","article-title":"Impact of restarting warfarin therapy in renal disease anticoagulated patients with gastrointestinal hemorrhage","volume":"35","author":"Khalid","year":"2013","journal-title":"Ren Fail"},{"key":"10.1016\/j.cgh.2026.07.002_bib25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ajg.2014.398","article-title":"The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study","volume":"110","author":"Sengupta","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.07.002_bib26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1053\/j.gastro.2016.04.013","article-title":"Risks of bleeding recurrence and cardiovascular events with continued aspirin use after lower gastrointestinal hemorrhage","volume":"151","author":"Chan","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.07.002_bib27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1160\/TH16-07-0498","article-title":"Optimal timing of vitamin K antagonist resumption after upper gastrointestinal bleeding. A risk modelling analysis","volume":"117","author":"Majeed","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cgh.2026.07.002_bib28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/MCG.0000000000000821","article-title":"Resumption of warfarin after hospitalization for lower gastrointestinal bleeding and mortality benefits","volume":"52","author":"Patel","year":"2018","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2026.07.002_bib29","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.cgh.2018.05.005","article-title":"Rebleeding vs thromboembolism after hospitalization for gastrointestinal bleeding in patients on direct oral anticoagulants","volume":"16","author":"Sengupta","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.07.002_bib30","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cgh.2017.12.032","article-title":"Rebleeding and mortality after lower gastrointestinal bleeding in patients taking antiplatelets or anticoagulants","volume":"17","author":"Oakland","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.07.002_bib31","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/apt.15441","article-title":"Risk of rebleeding, vascular events and death after gastrointestinal bleeding in anticoagulant and\/or antiplatelet users","volume":"50","author":"Sostres","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.07.002_bib32","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1177\/1060028020912429","article-title":"Outcomes associated with resuming direct oral anticoagulant therapy following admission for a gastrointestinal bleed","volume":"54","author":"Valanejad","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cgh.2026.07.002_bib33","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1111\/jth.15476","article-title":"Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: communication from the ISTH SSC Subcommittee on Control of Anticoagulation","volume":"19","author":"Candeloro","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cgh.2026.07.002_bib34","doi-asserted-by":"crossref","first-page":"E304","DOI":"10.1503\/cmaj.201433","article-title":"Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding","volume":"193","author":"Little","year":"2021","journal-title":"CMAJ"},{"key":"10.1016\/j.cgh.2026.07.002_bib35","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cgh.2020.11.029","article-title":"Restarting warfarin vs direct oral anticoagulants after major gastrointestinal bleeding and associated outcomes in atrial fibrillation: a cohort Study","volume":"20","author":"Tapaskar","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.07.002_bib36","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s11739-023-03299-4","article-title":"Optimal antiplatelet therapy for patients after antiplatelet therapy induced gastrointestinal bleeding: timing","volume":"18","author":"Xiao","year":"2023","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.cgh.2026.07.002_bib37","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/postmj\/qgaf090","article-title":"Risk of gastrointestinal rebleeding in direct oral anticoagulant-treated population","volume":"101","author":"Morarasu","year":"2025","journal-title":"Postgrad Med J"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526005148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526005148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T19:43:34Z","timestamp":1787514214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356526005148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"alternative-id":["S1542356526005148"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2026.07.002","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Timing of Antiplatelet and Anticoagulant Therapy Resumption Following Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2026.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}]}}